Identification of FOXM1‐induced epigenetic markers for head and neck squamous cell carcinomas

Abstract

Given that epigenetic change precedes gene expression, methylation status of candidate genes identified from this study may represent a signature of premalignancy, rendering them potentially useful predictive biomarkers for precancer screening and/or therapeutic targets for cancer prevention.